The Center for Skeletal Research (CSR), funded by the National Institute of Artritis and Musculoskeletal Diseases (NIAMS), is announcing a request for Pilot and Feasibility Research proposals ($35,000/year) The Awardees will be expected to present progress to CSR members biannually and provide a written annual report. Basic, translational, and clinical studies are welcome, though no clinical trials are allowed. Prior CSR P&F awardees are not eligible.

LETTER OF INTENT DUE TUESDAY, MARCH 25, 2024 AT 5PM EST

Letter of intent should include

• a 250 word abstract
• a 150 word statement of eligibility
• an NIH style biosketch including all other support.

Please submit in a single PDF file to csrmail@partners.org

In the subject line include your last name and “P30P+F LOI”  eg: SmithP30P+F LOI

THOSE INVITED TO APPLY FOR FUNDING WILL BE INFORMED BY Monday, April 1, 2024

A three-page scientific proposal will be due on April 19, 2024 at 5PM EST.

Expected funding date (depending on NIH approval) Monday, August 5, 2024

Eligibility is based on the criteria listed below:

1. Early career faculty proposing research projects related to musculoskeletal diseases and disorders, with the goal of generating preliminary data sufficient to support an application for independent NIH research support. Applicants in this group must meet the NIH Early Investigator Criteria(e.g, investigators who have had less than 10 years of research or research training experience after the completion of their terminal research degree or residency, see http://grants.nih.gov/grants/new_investigators/index.htm). Awardees of K grants may apply with committed effort but cannot receive salary from the P&F.
2. Established investigators from outside the musculoskeletal field proposing innovative studies relevant to musculoskeletal diseases and disorders.
3. Established investigators proposing studies relevant to musculoskeletal diseases and disorders that represents a clear departure from their established line of investigation.

Investigators must invest at least 1 calendar month of effort.  If salary requests do not reflect this effort, cost-sharing plans must be indicated. Applicants who are not U.S. citizens or permanent U.S. residents must have active visas permitting them to remain in the U.S. for the full period of the proposed research.

Per NIAMS rules, interventional clinical studies are not allowed.

Previous P30 P&F awardees will be allowed to re-apply for an additional year of funding.

Note:  click here to access the form for requesting an extension in the Early-Stage Investigator (ESI) and Early Established Investigator (EEI) Period.

Click here for downloadable announcement.